1 |
Ishay Y, Rotnemer-Golinkin D, Ilan Y. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways. Int J Immunopathol Pharmacol 2021;35:20587384211053274. [PMID: 34789044 DOI: 10.1177/20587384211053274] [Reference Citation Analysis]
|
2 |
Zhang YY, Ning BT. Signaling pathways and intervention therapies in sepsis. Signal Transduct Target Ther 2021;6:407. [PMID: 34824200 DOI: 10.1038/s41392-021-00816-9] [Reference Citation Analysis]
|
3 |
Wang Y, Liu YJ, Xu DF, Zhang H, Xu CF, Mao YF, Lv Z, Zhu XY, Jiang L. DRD1 downregulation contributes to mechanical stretch-induced lung endothelial barrier dysfunction. Theranostics 2021;11:2505-21. [PMID: 33456556 DOI: 10.7150/thno.46192] [Reference Citation Analysis]
|
4 |
Chen L, Li L, Song Y, Lv T. Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice. Inflammation 2021. [PMID: 34109517 DOI: 10.1007/s10753-021-01490-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
5 |
Miao H, Chen S, Ding R. Evaluation of the Molecular Mechanisms of Sepsis Using Proteomics. Front Immunol 2021;12:733537. [PMID: 34745104 DOI: 10.3389/fimmu.2021.733537] [Reference Citation Analysis]
|
6 |
Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Reference Citation Analysis]
|